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Abstract
Given a mathematical model quantifying the viral
infection of pandemic influenza H1N1pdm09-H275
wild type (WT) and H1N1pdm09-H275Y mutant
(MUT) strains, we describe a simple method of
estimating the model’s constant parameters using
Monte Carlo methods. Monte Carlo parameter
estimation methods present certain advantages
over the bootstrapping methods previously used in
such studies: the result comprises actual parameter
distributions (posteriors) that can be used to
compare different viral strains; the recovered
parameter distributions offer an exact method to
compute credible intervals (similar to the
frequentist 95% parametric confidence intervals
(CI)), that, in turn, using a suitable analysis
statistic, will be narrower than the ones obtained
from bootstrapping; given an appropriate
computational parallelization, Monte Carlo
methods are also faster and less computationally
intensive than bootstrapping. We fit Gaussian
distributions to the parameter posterior
distributions and use a two-sided
Kolmogorov-Smirnoff test to compare the two
strains from a parametric point of view; our
example result shows that the two strains are 94%
different. Furthermore, based on the obtained
parameter values, we estimate the reproductive
number R0 for each strain and show that the
infectivity of the mutant strain is larger than the
wild type strain.
Keywords: mathematical virology; Monte Carlo;
parameter estimation; likelihood;
Kolmogorov-Smirnoff
1 Introduction
The World Health Organization (WHO) declared the
first influenza pandemic of the 21st century in 2009
and described the virus (H1N1pdm09) as naturally
resistant to adamantanes but susceptible to the neu-
raminidase (NA) inhibitors oseltamivir and zanamivir
[1, 2]. The H275Y mutation within the NA gene was
reported to be associated with the drug resistance over
the past three years although the overall level of re-
sistance has remained relatively low The pandemic
strain completely displaced the prior seasonal H1N1
strain (A/Brisbane/59/2007) [1], which, in the 2008-
2009 season, was nearly 100% resistant to oseltamivir
[3]. It was initially thought that the mutation usually
compromised strain fitness (30), therefore the domi-
nance of an oseltamivir-resistant strain is rather sur-
prising. A return to widespread oseltamivir resistance,
with a mutated H1N1pdm09 virus, could have signifi-
cant public health consequences [1].
The H275Y amino acid substitution of the neu-
raminidase gene is the most common mutation con-
ferring oseltamivir resistance in the N1 subtype of the
influenza virus. Using a mathematical model to ana-
lyze a set of in vitro experiments that allow for the
full characterization of the viral replication cycle, [4]
show that the primary effects of the H275Y substitu-
tion on the pandemic H1N1 (H1N1pdm09) strain are
to lengthen the mean eclipse phase of infected cells
(from 6.6 to 9.1 h) and decrease (by 7–fold) the viral
burst size, i.e. the total number of virions produced per
cell; [4] also find, however, that the infectious–unit–
to–particle ratio of the H275Y mutant strain is 12-fold
higher than that of the oseltamivir-susceptible strain
(0.19 versus 0.016 per RNA copy). The multicompart-
ment mathematical model presented in [4] makes use
of ordinary differential equations (ODE) to describe
the virus as a dynamical system that undergoes dif-
ferent phases of evolution; the model is characterised
by a set of model parameters θi that [4] estimate us-
ing bootstrapping. We will use the same mathematical
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model approach (albeit with a changed set of ODEs)
and data set used in [4] but employ a different param-
eter estimation method – we will use a set of Markov
Chain Monte Carlo (MCMC) codes to robustly esti-
mate θi parameter values and credible intervals from
posterior distributions obtained from the MCMC sim-
ulations. Our results, combined with a minimal num-
ber of prior assumptions about the data, provide a
more precise set of values for the viral parameters θi
and the method could be standardized and used in the
future as a stand-alone parameter estimation package
for viral infectious disease modelling purposes.
The primary aim of this work is to show the benefits
of using MCMC parameter estimation techniques over
the traditional bootstrapping methods presented in,
e.g. [4]; secondary aims, connected to the primary, are
to introduce the reader to the theoretical support of
the analysis method, present a number of steps taken
to optimize the MCMC analysis process (resolving
computational issues with the numerical ODE solver,
changing the ODE model to a more computationally-
robust form) and to re-state and refine the results pre-
sented in [4] as obtained from using a different and
more precise analysis method. As a whole, this work
presents an easily standardizable analysis method for
any given biological data set that can be described by a
mathematical model whose parameters need to be es-
timated robustly and fast; the theoretical framewrok is
mostly Bayesian - with the only exception of the use of
a frequentist test comparing parametric distributions.
This article is divided as follows: in Section 2 we
will present the theoretical fundamentals that we use
throughout – the mathematical model that describes
the viral infection dynamics together with its param-
eters are described in [4], what we will outline is the
Bayesian support of the MCMC method and the statis-
tic used for the proposed method of estimation; in
Section 4 we describe the computational challenges
poised by the MCMC method – corrections applied
to the numerical integration of the model’s ODE set
and a rewritten, more computationally-robust, ODE
model; in Section 5 we present the results of the study
and formulate a discussion around the main conclud-
ing points, presented in the last section, Section 6.
2 Theoretical aspects
A virus undergoes a number of phases in its trajectory
towards infection and replication: (in brief) it will at-
tach and enter the host cell, inject its genetic material
and convert the cell to become a virus producer and
then it will exit the host and repeat the cycle [5]; these
phases can be modelled mathematically looking at the
virus and host cells as two distinct populations. Math-
ematical models have been applied to simulate viral
disease spread characteristics before [6, 4, 5] – approx-
imating the virus with a dynamical system that can
be characterised by a set of state variables and a set of
parameters, an ODE system will quantify the relation
between the state variables and their rate of change
with time. For this work in particular, viral yield mea-
surements may be simulated by using the following
multicompartment ODE model, as described in [4]:
V˙PFU = ρp
 nI∑
j=1
Ij
− (c+ cRNA)VPFU
V˙RNA = p
 nI∑
j=1
Ij
− cRNAVRNA
T˙ = −βTVPFU
E˙1 = βTVPFU − kE0, where k = nE/τE
E˙i = −k∆E
I˙1 = kEnE − δI0, where δ = nI/τI
I˙j = −δ∆I
D˙ = −δInID (1)
with E0 and I0 the values of E and I in the first
eclipse and infectious compartments respectively and
∆E = Ei − Ei−1 and ∆I = Ij − Ij−1 and that de-
scribes the infection of a population of N suscepti-
ble target cells T at a rate βVPFU, here VPFU is the
quantity of infectious virus. Newly infected cells first
undergo an eclipse phase E of average duration τE be-
fore becoming infectious I and producing virus at a
constant rate p for an average time τI ; VRNA repre-
sents the total (number of RNA copies/ml) virus con-
centration, controlled by the virus production rate p
(number of RNA copies/ml/h), the conversion factor
between virus produced and virus observed by titra-
tion ρ (no of PFU/RNA copies), the rate at which in-
fectious virus lose infectivity c (virus decay rate, 1/h),
and a rate of virus particle loss cRNA. Here nE and nI
are the numbers of eclipse and respectively infectious
compartments and the virus particle production rate
per cell, pRNA is defined as from [4]
pRNA = 0.5× 106 × p (2)
To determine the in vitro infectivity of a particular
strain, [4] used the infecting time
tinfect =
√
2
ρpβ
(3)
which is the amount of time required for a single in-
fectious cell to cause the latent infection of one more,
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within a completely susceptible population. In the
same framework we define the reproductive number
R0, the number of cases one case generates on average
over the course of its infectious period, in an otherwise
uninfected environment:
R0 =
ρpβ
c+ cRNA
(4)
The model in equation (1) (composed of the time-
differential equations X˙k(θi, t) = 0 with k state vari-
ables Xk and constant model parameters θi) describes
the virus; we would like to test if this model describes a
certain data set of discrete time points xj(t). In doing
so we solve the differential equations and fit the solu-
tions to the data; this process makes use of minimizing
the error function:
SSR =
∑
j
(X0kf(θi, tj)− xj)2 (5)
or the sum of the squared residuals (SSR) rj =
X0kf(θi, tj) − xj with respect to the parameter set
θi, where Xk(tj) = X0kf(θi, tj) ≡ qj is a solution of
the X˙k(θi, t) = 0 differential system in the vicinity of
the jth data point and X0k is the state variable Xk’s
initial value. We see immediately that both the nature
of any given minimum of the SSR for a given parame-
ter set and that very same recovered parameter set θi
will depend on the initial conditions X0k(
∂SSR
∂θ
)
i
= 0→
(
∂f(θ,X0k)
∂θ
)
i
= 0 (6)
Lest to say, initial values represent themselves a field
of its own and how they are treated is very important
to the final analysis outcome – for brevity, we will state
that all our initial parameter values are to be chosen
within physically and biologically motivated intervals;
we will update the reader as to our choice of initial
values for each of the experiments described here.
Our data xj is composed of four data sets for which
the two measured (explicit) state variables Xk(tj) are
the infectious viral load VPFU = VPFU(tj) and the total
amount of virus VRNA = VRNA(tj). All other state vari-
ables (number of cells T (t), number of cells in eclipse
phase E(t) etc.) are derived from the system (1) with
appropriate physical initial conditions e.g. T0 = 10
6,
E0 = I0 = D0 = 0. The system’s fixed parameters θi
are to be estimated using a fitting-to-data algorithm
that will sample values for θi from a parameter space
with the aim of minimizing the error function (5) by
means of (6); specifically, our set of parameters
θi ⊂ [τE , τI , nE , nI , β, c, cRNA, ρ, p] (7)
The sampling process and minimization of the SSR can
be efficiently done by using a Monte Carlo method.
The principle behind any given Monte Carlo analysis
[7, 8] is the Markov Chain (MC) – a memoryless chain
that can be easily represented by a particle jumping
through a set of consecutive states towards the state
of lowest potential energy; in this process, the particle
will retain only the information describing the current
and immediately previous states in order to decide if
the step is viable or not, all other information is for-
gotten. The particle will decide to jump states only
based on these two pieces of information: if the energy
of the next state is lower than the previous one, the
particle will jump states. More generally, we want to
generate random draws from a target parametric dis-
tribution Γ(θi). We then identify a way to construct
a Markov Chain such that its equilibrium probabil-
ity distribution is the target distribution Γ. If we can
construct such a chain then we arbitrarily start from
some point in the parameter space and iterate the MC
many times. Eventually, the draws we generate would
appear as if they are coming from our target distribu-
tion. We then approximate the quantities of interest
(e.g. mean) by taking the sample average of the draws
after discarding a few initial draws (“burn-in” draws)
which is the Monte Carlo component. There are several
ways to construct Markov Chains (e.g., Gibbs sampler,
Metropolis-Hastings algorithm [8]).
In the absence of noise, given a set of MCMC “walk-
ers” (an elementary particle undergoing a “random
walk”, a physical approximation of the exploration
of the Markov state space) exploring the parameter
space θi, the MCMC engine will minimize the residu-
als rj i.e. solve the ODE system X˙k(θi, t) = 0 given
by (1), obtain values for the error function SSR from
equation (5) for θi and the walkers will converge to-
wards a parametric position where the SSR has a min-
imum (whether it be local or global); in terms of distri-
butions, assuming no major physical noise source af-
fecting the measurements in a systematic manner and
an almost perfect mathematical model across all data
sets, residuals rj are normally distributed and the SSR
has a χ2 distribution with p degrees of freedom. Using
the probability distribution function (PDF) of a χ2-
distributed variable and the empirical condition that
the lower the SSR the better the model fit to the data,
the likelihood in a maximum likelihood estimation case
may be given by equation (8)
`(SSR) = Ce−SSR/2 (8)
where C is a constant for a given p degrees of free-
dom. By definition, equation (8) gives the likelihood
of a walker transitioning from a given state, charac-
terised by a certain parameter set, to a current state
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characterised by a parameter set θi and a fitting error
SSR(θi).
From the Bayesian perspective, there are known and
unknown quantities: the known quantity is the data,
represented by the number of discrete time points
xj(tj) (evidence); the unknown quantity is the proba-
bility P (θi|xj , z) – the posterior distribution of param-
eters θi given evidence xj and a model z (e.g. system
(1)). Using Bayes’ rule, this probability function can
be written:
P (θi|xj , z) = P (θi)P (xj , z|θi)
P (xj , z)
=
P (xj , z|θi)P (θi)∫ 1
0
P (xj , z|θi)P (θi)dθi
=
`(SSR)P (θi)∫ 1
0
`(SSR(θi))P (θi)dθi
(9)
Assuming a flat prior i.e. P (θi) = 1, and a finite con-
stant value for the integral h0 =
∫ 1
0
`(SSR(θi))P (θi)dθi,
it follows from equation (9)
P (θi|xj , z) →
=
`(SSR)
h0
= Ae−SSR/2 (10)
or
P (θi|xj , z) ∝ `(SSR) (11)
It is easy to understand P (θi|xj , z) now, as the poste-
rior distribution of parameters θi, the very same above
mentioned distribution Γ(θi) ≡ P (θi|xj , z) in which
the MCMC walkers will walk through i.e. which the
MCMC analysis will repeatedly sample to obtain a set
of values for the SSR. The walkers will aim towards
regions of low SSR (valleys) and there they will ex-
plore the parameter space in a more thorough manner
(higher sampling rate) until they will reach an SSR
minimum, where the sampling will cease and the chain
will end. There is one danger to this process: certain
walkers may have the tendency, highly dependent on
the initial parameter values, to converge to a local min-
imum that is sometimes rather far from the global min-
imum. The global minimum needs to be reached since
a local minimum can often present us with relatively
small fitting errors (SSRs) but a completely different
set of parameter values from the true values given by
reaching the global minimum. This is why it is nec-
essary to “aid” the MCMC walkers to step over these
local valleys, by setting a correct analysis statistic, fol-
lowing in the next section.
3 Weighted analysis statistic
Let’s introduce now the four independent experiments
that we have data for (the data for this work was taken
from [4], publicly available in the form of viral load
time evolution curves); all four data sets are modelled
by the same ODE system (1) that uses the same set
of parameters θi as presented in [4] and in equation
(7). These four experiments are called single-cycle viral
load measurement (SC), multiple-cycle viral load mea-
surement (PFUMC), multiple-cycle RNA load mea-
surement (RNAMC) and mock yield viral load mea-
surement (MY); for an in-depth description of each of
these experiments and how they were carried, consult
[4], it is not the purpose of this work to describe the
experiments from a methodological point of view since
the author has not conducted any of the experiments,
nor he had he any involvement in the data collection
procedure. It is, however, important to mention that,
from a statistical point of view, some parameters are
better recovered by fitting the model to only a cer-
tain subset of the four data sets than the entire set.
In [4] the same ODE model is applied to all four data
sets, and it is assumed that the SSR values have sim-
ilar distributions across the data sets (χ2 with equal
degrees of freedom p or log-normal distributions with
equal means and variances), therefore the sum of the
SSR values of the individual SC, PFUMC, RNAMC
and MY experiment components was used as overall
analysis statistic
SSR = SSRSC + SSRPFUMC +
+ SSRRNAMC + SSRMY (12)
In reality, due to high levels of experimental noise (that
we do not account for here and [4] does not analyze
either) and due to the mathematical model perform-
ing in an uneven manner in describing the data sets,
these SSR components do not have log-normal distri-
butions but rather are χ2 distributed with different de-
grees of freedom p. For simplicity, we will approximate
these distributions as log-normal but we will apply
weights to each SSR component in the following man-
ner: from performing 10,000 fitting trials with param-
eters randomly sampled from a 10-dimensional para-
metric “box” (see Table 2), we obtain the SSR compo-
nent distributions shown in Figure 1. Fitting normal
distributions in log-normal space, we obtain a set of
reference numbers in Table 1. We must stress upon
the fact that the log-normal approximation does not
play any other role in the likelihood formulation apart
from assigning weights to the different SSR compo-
nents. From Table 1 we see an approximately twofold
contribution from the PFUMC component to the over-
all SSR sum. This is an average effect, for a given
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SSR component Mean Std. Dev.
SC 136.0 3.2
PFUMC 308.0 4.0
RNAMC 98.0 3.6
MY 12.7 2.9
Combined 689.0 3.0
Table 1 Measures of SSR component means and variances,
when assuming log-normal distributions, from running 10,000
fitting trials with parameters randomly sampled from the
parameter “box” in Table 2.
uniformly sampled parameter box with large sampling
boundaries, and does not reflect any local behaviour
of the SSR components w.r.t. the additive overall SSR
(12).
0 1 2 3 4 5
log(SSR(SC))
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
SSR(SC)
0 1 2 3 4 5
log(SSR(PFUMC))
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
SSR(PFUMC)
0 1 2 3 4 5
log(SSR(RNAMC))
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
SSR(RNAMC)
0 1 2 3 4 5
log(SSR(all))
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
SSR all
SSR components/SSR cummulative distributions
Figure 1 SSR components distributions; last panel – additive
overall SSR (the sum of components, equation (12))
distribution; normal distributions are fitted (dashed lines) and
their means and variances are shown in Table 1.
This effect has implications when performing a pa-
rameter estimation analysis: if there are no weights
applied on the SSR components, on average, the pa-
rameter subset that optimally describes the PFUMC
data set will always be dominant. Poorly constrained
parameters, in the case of using an additive unweighed
likelihood from four data sets, have a very low recover-
ability for certain regions of the parameter space where
one or more components of the likelihood can not con-
strain effectively the others. In terms of error analysis,
in these regions, the Gaussian-stationary distribution
of the residuals (mean zero and variances equal for all
four data sets) is not effective any more.
Weighting the SSR components has to be done based
on each component’s χ2 distribution parameters (num-
ber of effective degrees of freedom), but because it is
quite difficult to account for effective degrees of free-
dom in order to weigh the likelihood components (de-
fined as number of data points minus number of ef-
fective model parameters), we could devise a simple
method to weigh by component by re-writing the to-
tal SSR:
SSRnew =
a=4∑
a=1
SSRa
na
(
1 +
SSRa
SSR0,a
)
(13)
where a = 4 is the number of components – PFUSC,
PFUMC, RNAMC and MY, na is the number of points
per data set a, and SSR0,a is a fixed threshold value
for each of the data sets, that aids the MCMC walkers
to move rapidly away from a parameter region that
yields relatively low SSR values but poor parameter
values (a “steep valley” of a local minimum). For a
fixed SSR0,a = 250 the new SSR compared to the
simple additive SSR, will have the same profile for low
values and a much stronger profile for high values, see
Figure 2. Thus, from equation (13) the likelihood (8)
10-1 100 101 102 103 104
SSR
10-1
100
101
102
103
104
105
106
SS
R/
ne
w
SS
R
newSSR
Figure 2 New weighted SSR (from equation (13), continuous
line) compared to standard unweighed additive SSR (from
equation (12), dashed line), as used in previous works as
analysis statistic.
will be rewritten to
` = Cexp
(
−
a=4∑
a=1
SSRa
2na
(
1 +
SSRa
SSR0,a
))
(14)
By definition, equation (14) gives the likelihood of a
walker transitioning from a given state, characterised
by a certain parameter set, to a current state char-
acterised by a parameter set θi and a weighted and
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thresholded fitting error SSR(θi). By weighting and
thresholding the standard additive SSR and construct-
ing likelihood (14), we will aid the MCMC walkers to
converge faster to the low SSR region and find the
global minimum corresponding to min(SSR).
4 Computational aspects: optimal
integrator settings and functional
expression of the model
Now that we have the four data sets, a model (1) with
parameters (7) to be estimated, and a likelihood (14)
function, we are ready to use an MCMC engine to
obtain posterior distributions (11) of our parameters.
For an MCMC engine we used emcee, presented in [9].
emcee is a Python-based, fully-parallelizable, MCMC
engine that takes a likelihood expression ((14) in our
case) and a set of initial values to sample the parameter
posteriors. emcee is becoming a preferred tool to data
analysis from different fields, see [10, 11] for examples
of its practical use.
In order to simulate the full set of MCMC production
runs with emcee, and since at each iteration, to be
able to compute the likelihood, the SSR function (13)
needs to be computed, we ran a set of 20,000 fitting
trials with parameters randomly sampled from a 10-
dimensional “box” with dimensions listed in Table 2.
The dimensions for this “box” were chosen based on
phenomenology of the viral data – the “box” is large
enough to comprise most possible parameter values hit
by the MCMC walkers
As a result of these test runs, we have noticed failure
rates of 16-18% of the ODE solver, a rather significant
fraction when performing a full production MCMC
analysis. A few of the failed cases are shown in Figure
3, where the dots represent the actual data points and
the lines represent the solutions offered by the solver.
These are consequences of system (1) being a stiff
ODE system. In mathematics, a stiff differential equa-
tion is an equation for which certain numerical meth-
ods for solving it are unstable, unless the step size is
taken to be extremely small [12]. It has been proven
difficult to formulate a precise definition of stiffness,
but the principal idea is that the equation includes
some terms that can lead to rapid variations in the
solution. While simulating the MCMC runs, we have
noticed the failure of the employed numerical integra-
tor – Scientific Python’s scipy.integrate.odeint() – to
give exact solutions to the ODE system and initially
there was no simple rule or pattern to where the in-
tegrator failed. These failures are grouped as follows,
depending on the type of exit output:
• The most frequent exit case of the integration pro-
cess was associated with Python’s “math domain
error”, a typical computing error that occurs when
(in our case) the routine tries computing a loga-
rithm of a negative real number – in this case, the
computation of the SSR value was not completed
due to negative values of the PFUMC viral load;
this error would be recorded for another case as
well: the integrator would fail due to the need for
a larger number of integration steps (larger than
the default maximum of 500) – in this case the
integration would be done up to a certain point
where a steep change in the V (t) curve, the in-
tegrator would exit and the rest of the viral load
values would be of order 10−300, below the ma-
chine precision of numpy.log10;
• On occasions, we noticed ’NaN’ values of the SSR,
produced by positive but infinitesimally small val-
ues of viral output, referring us to the previous
case;
20 0 20 40 60 80 100 120 140
Time (h)
10-13
10-11
10-9
10-7
10-5
10-3
10-1
101
103
105
107
109
1011
Vi
ru
s 
lo
ad
 (P
FU
/m
l)
Negative Viral Load: PFUMC - Y275
Figure 3 Failed integrations with scipy.integrate.odeint()
exiting with Python’s “math domain error” (solutions obtained
using the parameter sets drawn from the “box” given in Table
2; we notice a series of problematic behaviour types of the
solutions – oscillations (with different amplitudes and
frequencies) at artificially very low values of viral load
VPFUMC(t), typical cases of solver’s incapacity to reach a
stable solution.
The scipy.integrate.odeint(f(t), t, y0, ∗args) ODE
integrator (see documentation available here http://
docs.scipy.org/doc/scipy/reference/generated/
scipy.integrate.odeint.html) uses an adaptive
timestep Runge-Kutta 4-5 method written inside its
Fortran solver library (see http://docs.scipy.org/
doc/numpy/user/install.html for included compiler
instructions) to integrate systems of ordinary differ-
ential equations. The number of time steps taken
by the integrator varies but is capped by default at
mxstep=500. Also, the odeint function takes a list
of output timesteps, but the Fortran routine is called
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Parameter Min. value Max. value
p(1/h)
max(VPFUMC)
∗
104
102× max(VPFUMC)
β(1/h) 10−3 × max(VRNAMC)
(max(VPFUMC))
2 10
3 × max(VRNAMC)
(max(VPFUMC))
2
c(1/h) 0.01 1.0
cRNA(1/h) 0.001 0.1
ρ 10−5 1.0
τE(h) 3.0 30.0
τI(h) 0.1 60.0
V ∗∗0MC(PFU/ml)
V0PFUMC
105
102 × V0PFUMC
* max(VPFUMC) represents the maximum viral load from the PFUMC data set;
** V0MC represents the initial value for the PFUMC viral load, parameter to be estimated as well.
Table 2 The parametric 10-dimensional “box” from wich we randomly sampled parameters for the 20k ODE solving trials.
once for each desired output and uses the previous
call as the initial conditions for the next one. This can
prove detrimental in cases where the specified time
points where the integral should be evaluated is small
(order 12-16, as in our data sets). The problem arises
from the fact that, unlike more stable but slower MAT-
LAB integrators, odeint does not use only the initial
and final time points to generate a smooth, continu-
ous integral and further on use interpolation to get the
function values at each time point; it rather integrates
piecewise for each segment determined by the specified
time points series, process that is prone to breaking if
there are too few time points to allow for continuity.
One solution to this problem is to increase the pa-
rameter mxstep - the number of integration steps –
that is capped by default at 500. Increasing mxstep to
5000 or 10000 would insure that even for order 12-16
data points the integrator will solve the system for all
the specified time points, and will not exit without
reaching a stable solution.
Unfortunately, increasing the maximum number of
integration steps mxstep will affect the time it takes
scipy.odeint to solve a system: if the system is solv-
able with the default maximum mxstep ≤ 500, by in-
creasing mxstep to, say, 10000, will not increase the
solving time, as seen from Table 3; increasing mxstep
will only increase the integration time for systems that
scipy.odeint can not solve for a given number of time
points and will exit after the first one or two integra-
tion points, most of the cases we are faced with. Table
3 shows the time it took the solver to integrate 100
times the same ODE system, with the same param-
eters, same initial conditions, same initial and final
time, only with different numbers of integration time
points and mxsteps. Thus, using a larger mxstep than
the system default one is a necessary option for an
MCMC production run, but it will, in turn, increase
the processing time.
One could apply corrections for accuracy by chang-
ing the default values for tolerances rtol and atol (in-
ternal ODE solver error handling parameters, see doc-
umentation at http://docs.scipy.org/doc/scipy/
12 time points Time/100 runs
mxstep=5e2 dt= 51.8s
mxstep=1e3 dt= 169.8s
mxstep=1e4 dt= 167.9s
mxstep=1e6 dt= 221.9s
100 time points Time/100 runs
mxstep=5e2 dt= 188.6s
mxstep=1e3 dt= 188.9s
mxstep=1e4 dt= 189.9s
mxstep=1e6 dt= 206.4s
Table 3 Time it took scipy.odeint() to integrate 100 times the
same ODE system, with the same parameters, initial conditions,
initial and final time, only with different numbers of time points
and mxstep’s. The reason why for 12 time points and
mxstep=500 the run time is short is that the integrator exits
after the second or third time point with no valid solution.
reference/integrate.html) to orders of 10−30. The
problem with reducing the tolerance to very small val-
ues is that the solving for an otherwise exact within the
default tolerance solution will take much longer time
(of order 15-20 times longer than the solving without
adjusting tolerance) – this, in light of a set of numerous
MCMC simulations, could be a very much unwanted
behaviour.
There is, however, an alternative solution to the
ODE incapacity problem: by effecting a change of
state variable, we rewrite the ODE’s from system (1)
in an exponential manner. Our state variables are
T,Ei, Ij , VPFU, VRNA and D with i, j the number of
eclipse and infectious compartments respectively. Con-
sider Φ any of these real and positive defined state
variables. We will operate a change of variable that
will map Φ to a different real (both positive and neg-
ative defined) variable Ω with the following functional
relation:
Φ→ Φ := eΩ (15)
and this way the differential forms, by applying the
chain rule, will be:
dΦ
dt
=
(
∂Φ
∂Ω
)
t
(
∂Ω
∂t
)
Φ
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≡ ΦdΩ
dt
(16)
With this in mind we rewrite the computational form
of our ODE system (1) as:
V˙PFU = ρpe
−VPFU
j=nI∑
j=1
eIj
− (c+ cRNA)
V˙RNA = pe
−VRNA
j=nI∑
j=1
eIj
− cRNA
T˙ = −βeVPFU
E˙1 = βe
(T+VPFU−E0) − k
E˙i = ke
−∆E − k
I˙1 = ke
EnE−I0 − δ
I˙j = δe
−∆I − δ
D˙ = δeInI e−D (17)
with E0 and I0 the values of E and I in the first eclipse
and infectious compartments respectively and ∆E =
Ei − Ei−1 and ∆I = Ij − Ij−1.
The integration initial conditions are straightfor-
ward from (1) and (17): natural logarithms of the
original, non-exponential ODE system, i.e. V
(17)
PFU =
ln(V
(1)
PFU), V
(17)
RNA = ln(V
(1)
RNA), T
(17) = 0.0, E(17) =
I(17) = D(17) = −n where n is a relatively large natu-
ral number (30-100). The reason why E(17) = I(17) =
D(17) = −n is that we need a good approximation for
null initial conditions from E(1) and I(1) and these do
not introduce errors in the solver due to too small a
number.
We have tested the re-written ODE system (17)
against the one already in use (1) in [4]. Figure 4 (left)
shows system (17) finds the exact same solution for a
favourable best fit parameter set (the SSR was iden-
tical between the two systems (1) and (17) to preci-
sion order 10−5); the system (17) is more computation-
ally intensive and needs longer time to solve than the
non-exponentiated system (1); it also needs a larger
number of the maximum step value (we have obtained
the best fit curve with mxstep ≥ 4000). The time it
took system (17) to integrate with best fit parameters
was 48.9s (for 50 trials) whereas the non-exponentiated
system (1) took 29.6s for the same number of trials.
Figure 4 (right) shows the same comparison but with
a set of unfavourable parameters that would induce
the non-exponentiated system (1) to produce numeri-
cally unstable solutions (hence damped oscillatory be-
haviour); system (17) produces the correct solution
and in a shorter time - 55.3s (for 50 trials) whereas
the non-exponentiated system took 159.2s for the same
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Figure 4 (left) shows system 17 finds the exact same solution
for a favourable best fit parameter set (the SSR was identical
between the two systems (1) and (17) to precision order
10−5); the system (17) is more computationally intensive and
needs longer time to solve than the non-exponentiated system
(1); it also needs a larger number of the maximum step value
(we have obtained the best fit curve with mxstep ≥ 4000).
The time it took system 17 to integrate with best fit
parameters was 48.9s (for 50 trials) whereas the
non-exponentiated system (1) took 29.6s for the same number
of trials. (right) shows the same comparison but with a set of
unfavourable parameters that would induce the
non-exponentiated system (1) to produce numerically unstable
solutions (hence damped oscillatory behaviour); system (17)
produces the correct solution and in a shorter time - 55.3s (for
50 trials) whereas the non-exponentiated system took 159.2s
for the same number of trials, with a high percentage of
unstable solutions
number of trials, with a high percentage of unstable
solutions.
We repeated the 20,000 trials with parameters ran-
domly sampled from the “box” of Table 2 above but
using the system given by equation (17) this time. All
solutions were stable, so failure rate in computing a
numerical value for the SSR due to non-physical neg-
ative V (t) values is 0%.
5 Analysis and results
In order to obtain a set of “best fit” parameters i.e. a
set of parameters for which model (17) best describes
the data, we performed a number of ∼1500 bootstrap
runs. Any given bootstrap run is characterised by a
set of initial conditions (initial parameter values, ran-
domly chosen from the parametric “box” (Table 2), an
ODE system (17) and an error function that quanti-
fies how well the solution fits the data, given in equa-
tion (13); for the thresholds we chose values of order
3 times larger than the “best fit” values i.e. SSRa in
equation (13) we chose SSRSC = 10, SSRPFUMC = 8,
SSRRNAMC = 6 and SSRMY = 3 (‡). This ensemble
is passed to a least squares engine that walks the sys-
tem through a large combination of parameter values,
with each iteration coming closer to the global mini-
mum position in parameter space i.e. minimizing the
SSR. We then chose the single parametric combination
with the lowest SSR from these bootstrap runs. Such
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a global minimum “best fit” to the data is shown in
Figure 5 for three of our four data sets (SC, PFUMC
and RNAMC); the parameters for this case are used
to construct the intervals to start the MCMC walkers
from: the “best fit” parameter set is used as the center
of the interval with boundaries given by the mean of
all the bootstrap parameter values.
The bootstrapping process randomly samples the fit-
ting errors with replacement; this set is usually as-
sumed to be from an independent and identically dis-
tributed population, and it is implemented by con-
structing a number of resamples with replacement of
the same size as the initial set. The main problem of
using bootstrapping to estimate biological parameters
is that the mathematical model errors are not sampled
from the same distribution - the model is applied to
different data sets that it describes differently; there
is also the experimental noise that introduces fluctua-
tions in the fitting errors, but this we can not model in
this work. In our situation, using bootstrapping to es-
timate parametric confidence intervals will introduce a
bias towards the data set(s) that are worse described
by the model and the parametres will have broader
distributions, usually with heavy tails in the regions
where the model constrains poorly those data sets. On
the other hand, the MCMC analysis will not assume
all error samples are drawn from the same distribution
and will most often reject those parameter regions pro-
ducing the bootstrap distribution tails. This bing said,
using bootstrapping is a good way to obtain “best fit”
parameter intervals that can be further used as initial
values for the MCMC runs.
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Figure 5 “Best fit” curves of model (17) for the SC, PFUMC
and RNAMC data sets; parameters for these curves have been
used as centers for the intervals from which the MCMC
walkers have been started from, as their initial conditions.
The MCMC simulations have been run on multi-
ple CPU’s using the OpenMPI (Open Message Pass-
ing Interface http://www.open-mpi.org/) implemen-
tation in emcee package (see [9] and the guide at
[13] for instructions on how this mode is configured,
specifically MP4Py); the computational load has been
divided and managed on Compute Canada’s SHAR-
CNET academic and scientific-usage computer clus-
ters (https://www.sharcnet.ca/). The analysis pro-
cedure comprised the following specifications:
• According to emcee’s user manual [13] it is desired
to start each of the walkers from a favourable po-
sition in the parameter space – as such, we started
all the walkers on a tight ball centered at the “best
fit” parameters of each of the four experiments.
The “best fit” parameters are seen in Table 4 to-
gether with the walkers’ start intervals, labelled
as (1) columns;
• We ran 2000 iterations for each of the 100 walkers
per combined data sets (SC, PFUMC, RNAMC
and MY) with 200 iterations for burn-in; sam-
pling was performed in linear parameter space.
The emcee package needs just a few inputs to be
able to handle the MCMC simulations, the most
important input being the an expression for the
likelihood of accepting or rejecting the parameter
set of any given walker’s position in the parame-
ter space. This likelihood is given by equation (14)
and is directly coded in, making use of the SSR
thresholds (‡);
• Chains had average acceptance rates of 30-40%;
convergence and chain mixing was checked using
a Gelman-Rubin diagnostics test and chains that
did not reach convergence were discarded (the
Gelman-Rubin test [14] is used to check the con-
vergence of multiple MCMC chains run in paral-
lel; it compares the within-chain variance to the
between-chain variance);
• Only parameter sets from walkers with SSR¡5.0
were kept for final parameter estimation, the rest
of the sets being discarded.
The numerical results are presented in Table 4; the
listed parameter value (2) is the mean of posterior dis-
tributions obtained from the MCMC simulations; the
credible interval (3) is obtained from fitting a Gaussian
distribution to the posterior distribution, see Figure 6.
The Gaussian fit agrees very well with the actual pos-
terior distributions obtained from the MCMC simula-
tions.
In order to quantify the difference between the two
strains, WT-H275 and MUT-H275Y, from a paramet-
ric point of view, we construct the distance in param-
eter space Γ
λΓ =
√√√√ 1
N
i=N∑
i=1
(
KSi
wi
)2
(18)
where N is the number of estimated parameters, KSi
is the result of a two-sided Kolmogorov-Smirnoff test
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WT-H275 and MUT-H275Y data: emcee MCMC Simulations Results for ODE Model (17)
(1) - initial value interval; (2) - obtained median value; (3) - obtained credible interval from posterior distribution
Parameter (1)WT-H275 (2)WT-H275 (3)WT-H275 (1)MUT-H275Y (2)MUT-H275Y (3)MUT-H275Y
Mean eclipse period, τE (h) 6.6±3.0 6.6 6.3–7.1 9.1±3.0 9.3 9.1–9.6
Eclipse period SD, σE (h) 1.2±2.0 1.3 1.1–1.5 1.6±2.0 1.6 1.5–1.8
Infecting time, tinfect
1 (min) 31.0±15.0 22.2 19.7–23.8 22.0±15.0 18.6 17.8–19.8
Infectious life span, τI (h) 49.0±15.0 35.2 34.6–36.2 41.0±15.0 32.0 31.4–32.3
Depletion rate, c (h−1) 0.1±0.05 0.078 0.069–0.086 0.1±0.05 0.087 0.076–0.097
Production rate/cell, pRNA (RNA copies/h) 2,200±1,000 3,355 3,071–3,700 370±1,000 459 425–498
Viral burst size, b 2 (RNA copies) 110±50 118 109–131 15±50 15 13–16
Reproductive number, R0 3 2000±1500 3582 3101–4085 3000±1500 4243 3906–4572
1 Computed using equation (3); 2 Burst size b = pRNA × τI ; 3 Computed using equation (4).
Table 4 Viral infection parameters obtained from MCMC simulations with the emcee engine: initial values, median values, credible
intervals obtained from posterior distributions for both the wild type WT-H275 and the mutant MUT-H275Y H1N1pdm09 strains.
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Figure 6 Posterior distributions for four viral parameters: production rate/cell, pRNA (RNA copies/h, top left corner), mean eclipse
period, τE (h, top right corner), infectious life span, τI (h, bottom left corner) and infecting time, tinfect (min, bottom right corner)
for both WT-H275 and MUT-H275Y strain data; these distributions have been obtained by running a set of MCMC simulations
(emcee engine, 100 walkers, 2000 iterations) and Gaussian distributions have been fitted over (dashed lines) – the parameters of the
fitted distributions are listed in Table 4.
(see documentation at http://docs.scipy.org/doc/
scipy-0.14.0/reference/generated/scipy.stats.
ks_2samp.html) with inputs the two ith parameter
distributions for WT-H275 and MUT-H275Y (the null
distribution of this statistic is calculated under the
null hypothesis that the samples are drawn from the
same distribution; this test is used to determine how
“similar” two parametric distributions are, assuming
they are normal distributions; the choice of use of a
frequentist test over a Byesian one is that there al-
ready exists a scipy simple-to-use package that can
be called with ease when constructing a parameter-
estimation package) and wi is a set of weights that
are chosen function of the recoverability of ith param-
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eter (for simplicity we use wi = 1 here). We apply a
two-sided Kolmogorov-Smirnoff test using the fitted
Gaussian distributions. The KSi test results are listed
in Table 5. The statistic λΓ is a percentage that tells
us how different the two compared strains are, in our
case, from the MCMC estimated four parameters in
Table 5, the two strains are 94% different. Of course,
this rationale could be extended for a larger set of pa-
rameters, whichever are deemed as significant in the
case of comparison, here we are using equation (18)
with four parameters as an example only.
WT-H275 and MUT-H275Y data: Kolmogorov-Smirnoff test
results
From equation (18), λΓ = 0.94%
Parameter KSi (%)
Mean eclipse period, τE 0.99
Infecting time, tinfect 0.79
Infectious life span, τI 0.96
Production rate/cell, pRNA 1.00
Table 5 Kolmogorov-Smirnoff test results for four (example)
parameters.
6 Conclusions
We used the data from [4] in a bid to refine the
results presented there and formulate new concepts
to analytically compare virus strains; we used a dif-
ferent analysis method to estimate the viral dynam-
ics parameters of model (1) – Markov Chain Monte
Carlo simulations. We modified the model to a more
computationally-robust model (17), formulated a like-
lihood (14) and used an existing MCMC computer
package (emcee presented in [9]) to obtain parame-
ter distributions (posteriors). The MCMC results offer
much narrower credible intervals than bootstrapping
95% confidence intervals (see [4] for a result using
bootstrap replicates); they also offer true parameter
probability distribution functions (PDFs) in the form
of the posterior distributions: full parameter results
can be found in Table 4 and distributions are shown in
Figure 6. We used these distributions and fitted Gaus-
sian distributions to extract the credible intervals, the
Gaussian fit being rather good. In a novel approach, we
used a frequentist two-sided Kolmogorov-Smirnoff test
to compare the two viral strains, comparison yielding
a 94% difference from a parametric point of view. By
computing the reproductive number R0 we show that
the infectivity of the mutant strain is higher than the
wid type; this has been shown in [4] as well but our
values for R0 differ and suggest a smaller difference in
infectivity between the two strains; this is supported
by narrow credible intervals for R0, see 4.
Assuming a flat prior, the MCMC analysis method
we present here does not make use of any assump-
tions with regards to data, and, albeit the data is
very small (order 60 data points in total), the re-
sults are not only consistent with the ones presented
in [4] but parametric credible intervals are narrower
and we could obtain an analytic measure to distin-
guish the two H1N1pdm09 strains. The use of emcee
[9] is very easy and, if correctly configured in multi-
processor mode, the program runs very fast – we could
obtain the results we present here in a matter of one
day. If this analysis method is correctly packaged, one
could obtain this type of results in a matter of hours.
Using a generic mathematical model and this analysis
package could lead to results being obtained very fast,
matter that might be very useful in the future in the
case of a major pandemic.
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